Brought to you by:
SVS urges revisions for independent cardiology certification board
The Society for Vascular Surgery (SVS) has expressed conditional support for cardiology establishing an independent certification board but objects to provisions in the current American Board of Cardiovascular Medicine (ABCVM) proposal as they conflict significantly with the mission and requirements…
Acellular tissue-engineered vessel granted FDA Regenerative Medicine Advanced Therapy designation for advanced PAD
Humacyte recently announced it has been granted Regenerative Medicine Advanced Therapy (RMAT) designation from the US Food and Drug Administration (FDA) for its investigational acellular tissue-engineered vessel (ATEV), designed to treat patients with advanced peripheral arterial disease (PAD). This RMAT…
Grasping the nettle: The need to tackle PAD problem head on is huge, says 2024 Veith lecturer
Huge opportunities abound for vascular surgeons to take a leadership role on the frontlines of a developing peripheral arterial disease (PAD) treatment crisis in the U.S., says Michael Conte, MD, who gave the second annual Frank J. Veith Distinguished Lecture…
The top 10 most popular Vascular Specialist stories of June 2024
In June, the most read stories from Vascular Specialist included key reports from the 2024 Vascular Annual Meeting (VAM; June 19–22) covering TEVAR, CEA vs TCAR, PAD and CFA-reintervention, among others; Linda Harris’ placement as SVS vice president; the relationship…
Humacyte’s ATEV granted FDA Regenerative Medicine Advanced Therapy designation for advanced PAD
Humacyte recently announced it has been granted Regenerative Medicine Advanced Therapy (RMAT) designation from the US Food and Drug Administration (FDA) for its investigational acellular tissue engineered vessel (ATEV), designed to treat patients with advanced peripheral arterial disease (PAD). This…
Walk for PAD awareness this September
Registration for the Society for Vascular Surgery (SVS) Foundation’s 2024 Vascular Health Step Challenge is now open. The Foundation is hosting the third annual Step Challenge throughout the month of September in honor of Peripheral Arterial Disease (PAD) Awareness Month.…
Young vascular surgeons on the PAD frontier: ‘This is the time to seize the day,’ 2024 Veith Lecturer declares
Huge opportunities abound for vascular surgeons to take a leadership role on the frontlines of a developing peripheral arterial disease (PAD) treatment crisis in the U.S., said Michael Conte, MD, as he gave the second annual Frank J. Veith Distinguished…
Chickasaw Nation study exemplifies how diversity can boost patient access to specialized vascular care
A “feasible and reproducible” intervention bundle characterized by surveys, provider education and patient screening has demonstrated the potential to not only identify gaps in peripheral arterial disease (PAD) primary care practices, but also to help address them. This was a…
Toe and flow session aims to break down barriers to multidisciplinary limb salvage teams
“If you had cancer you would go to a cancer center where you would get a multidisciplinary approach,” SVS President Joseph L. Mills, MD, tells VS@VAM, drawing on this example to highlight the importance of multidisciplinary teams working for amputation…
VAM 2024: Enhancing clinical practice and patient interaction in CLTI
A key event on informed decision-making in chronic limb-threatening ischemia (CLTI) promises to be a highlight of the 2024 Vascular Annual Meeting (June 19–22). Funded by a grant from the Council of Medical Specialty Societies (CMSS) awarded to the SVS, the…